FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 2053250 · Received April 13, 2011

Report

Report Number
2124215-2011-04269
Event Type
Injury
Date Received
April 13, 2011
Date of Event
March 2, 2011
Report Date
April 8, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE LEAD HAS NOT BEEN RETURNED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THE LEAD WAS RETURNED SEVERED. ONE COIL WAS IN TWO PIECES FROM ELECTRO-CAUTERY MELTING IT. ELECTRO-CAUTERY ALSO MELTED THE INSULATION. DRIED BODILY FLUID HAD ENTERED THROUGH THE ENTIRE LEAD LUMEN. THE ALLEGATION OF LEAD DISLODGEMENT COULD NOT BE REPLICATED IN ANALYSIS, HOWEVER TECHNICIANS CONFIRMED THERE WERE NO ANOMALIES FOUND WITH THE HELIX OF THE LEAD.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR LEAD DISLODGED POST IMPLANT. THE LEAD WAS EXPLANTED AND REPLACED WITH A NEW LEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4456

Patients

Seq Age Sex Outcome Treatment
1 285 MO Life Threatening| R S602| 4136| 4469| 4456